Clinical Trials Browser

Phase 2/3 × Neoplasms × Immunotherapy × Clear all

NCT07000253 2025-06-02

OMEC-5

Phase 2/3 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms